Cleared Traditional

K182743 - Patient-Specific Airway Stent

K182743 is an FDA 510(k) clearance for Patient-Specific Airway Stent, manufactured by New Cos, Inc.. The device is a Class 2 Anesthesiology device with product code NWA cleared through the Traditional 510(k) pathway after a 390-day FDA review.

K182743 · New Cos, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
390d
Days
Class 2
Risk

K182743 is an FDA 510(k) clearance for the Patient-Specific Airway Stent. Classified as Prosthesis, Tracheal, Preformed/molded (product code NWA), Class II - Special Controls.

Submitted by New Cos, Inc. (Cleveland, US). The FDA issued a Cleared decision on October 23, 2019 after a review of 390 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 878.3720 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all New Cos, Inc. devices

FDA 510(k) Submission Details - K182743

510(k) Number K182743 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2018
Decision Date October 23, 2019
Days to Decision 390 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
250d slower than avg
Panel avg: 140d · This submission: 390d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NWA Device Classification - Class 2, Special Controls

Product Code NWA Prosthesis, Tracheal, Preformed/molded
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3720
Definition The Device Is Intended To Provide Support To Weakened Or Constricting Airway Walls.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - NWA Prosthesis, Tracheal, Preformed/molded

Devices cleared under the same product code (NWA) and FDA review panel - the closest regulatory comparables to K182743.
VisionAir Enhanced Stock Stent
K261541 · VisionAir Solutions · Jun 2026
TRACHEOBRONXANE™ DUMON®
K243126 · Novatech SA · Oct 2024
VisionAir Patient-Specific Airway Stent
K213969 · New Cos Inc. Dba Visionair Solutions · Oct 2022
ENDOXANE
K971509 · Novatech SA · Aug 1997
HOOD TRACHEAL & TRACHEAL-BRONCHIAL PROSTHESES
K873742 · Hood Laboratories · Oct 1987